AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation

被引:63
作者
Ghaffari, S [1 ]
Kitidis, C
Zhao, W
Marinkovic, D
Fleming, MD
Luo, B
Marszalek, J
Lodish, HF
机构
[1] CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, Brookdale Dept Mol Cell & Dev Biol, Dept Med,Div Hematol Oncol, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA
[3] Whitehead Inst Biomed Res, Cambridge, MA USA
[4] Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol, Boston, MA USA
[5] MIT, Dept Biol, Cambridge, MA 02139 USA
关键词
D O I
10.1182/blood-2005-06-2304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AKT serine threonine kinase of the protein kinase B (PKB) family plays essential roles in cell survival, growth, metabolism, and differentiation. In the erythroid system, AKT is known to be rapidly phosphorylated and activated in response to erythropoletin (Epo) engagement of Epo receptor (EpoR) and to sustain survival signals in cultured erythroid cells. Here we demonstrate that activated AKT complements EpoR signaling and supports erythroid-cell differentiation in wild-type and JAK2-deficient fetal liver cells. We show that erythroid maturation of AKT-transduced cells is not solely dependent on AKT-induced cell survival or proliferation signals, suggesting that AKT transduces also a differentiation-specific signal downstream of EpoR in erythroid cells. Downregulation of expression of AKT kinase by RNA interference, or AKT activity by expression of dominant negative forms, inhibits significantly fetal liver-derived erythroid-cell colony formation and gene expression, demonstrating that AKT is required for Epo regulation of erythroid-cell maturation.
引用
收藏
页码:1888 / 1891
页数:4
相关论文
共 25 条
[1]   Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation [J].
Bouscary, D ;
Pene, F ;
Claessens, YE ;
Muller, O ;
Chrétien, S ;
Fontenay-Roupie, M ;
Gisselbrecht, S ;
Mayeux, P ;
Lacombe, C .
BLOOD, 2003, 101 (09) :3436-3443
[2]   Advances in protein kinase B signalling:: AKTion on multiple fronts [J].
Brazil, DP ;
Yang, ZZ ;
Hemmings, BA .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (05) :233-242
[3]   Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB [J].
Dai, CH ;
Chung, IJ ;
Krantz, SB .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (02) :152-158
[4]  
DAMEN JE, 1993, BLOOD, V81, P3204
[5]   PHOSPHORYLATION OF TYROSINE-503 IN THE ERYTHROPOIETIN RECEPTOR (EPR) IS ESSENTIAL FOR BINDING THE P85 SUBUNIT OF PHOSPHATIDYLINOSITOL (PI)-3-KINASE AND FOR EPR-ASSOCIATED PI-3-KINASE ACTIVITY [J].
DAMEN, JE ;
CUTLER, RL ;
JIAO, HY ;
YI, TL ;
KRYSTAL, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23402-23408
[6]   Cellular survival: a play in three Akts [J].
Datta, SR ;
Brunet, A ;
Greenberg, ME .
GENES & DEVELOPMENT, 1999, 13 (22) :2905-2927
[7]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[8]   BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells [J].
Ghaffari, S ;
Wu, H ;
Gerlach, M ;
Han, Y ;
Lodish, HF ;
Daley, GQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13186-13190
[9]   Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOX03a transcription factor [J].
Ghaffari, S ;
Jagani, Z ;
Kitidis, C ;
Lodish, HF ;
Khosravi-Far, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6523-6528
[10]   Erythropoiesis in the absence of janus-kinase 2:: BCR-ABL induces red cell formation in JAK2-/- hematopoietic progenitors [J].
Ghaffari, S ;
Kitidis, C ;
Fleming, MD ;
Neubauer, H ;
Pfeffer, K ;
Lodish, HF .
BLOOD, 2001, 98 (10) :2948-2957